Research on Synergistic Regulation of Sleep-Emotion-Behavior Based on SLS Magnesium Glycinate Complex Liquid Supplement

© 2025 by the Authors. Licensee Whioce Publishing, Singapore. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )

Download PDF

Cite

XML

HTML

Abstract

Hyperactivity and tic symptoms in children and adolescents with Attention Deficit Hyperactivity Disorder (ADHD) have a bidirectional association with sleep disorders, while magnesium deficiency is a key nutritional factor exacerbating this vicious cycle. The SLS Magnesium Glycinate Complex Liquid Supplement formula adopts the core logic of "sleep improvement - mood stabilization - behavioral regulation" and enhances the neuromodulatory effects of magnesium ions through multi-component synergy. Tailored to the developmental needs of different stages aged 4-16 years, the formula features a child-friendly dosage design, forming a closed-loop regulation in aiding sleep, reducing tics, and maintaining daytime functioning. A 3-month clinical trial showed that the formula improved sleep efficiency by 15%-23%, reduced tic frequency by 21%-32%, and enhanced emotional stability scores by 24%-30% across all age groups with ADHD, with good safety and tolerability. This study provides a targeted nutritional intervention solution for ADHD, and its age-stratified design concept offers scientific reference for precise nutritional support during different developmental stages of children and adolescents.

References

Lycett K, Mensah F, Hiscock H, et al., 2014, A Prospective Study of Sleep Problems in Children With ADHD. Sleep Medicine, 15(11): 1354–1361.

O’Brien L, Ivanenko A, Crabtree M, et al., 2003, Sleep Disturbances in Children With Attention Deficit Hyperactivity Disorder. Pediatric Research, 54(2): 237–243.

Nestler E, Hyman S, Holtzman D, 1954, Molecular Neuropharmacology: A Foundation for Clinical Neuroscience, McGraw-Hill Medical, New York

Accardo J, Marcus C, Leonard M, et al., 2012, Associations Between Psychiatric Comorbidities and Sleep Disturbances in Children With Attention-Deficit/Hyperactivity Disorder. Journal of Developmental & Behavioral Pediatrics, 33(2): 97–105.

Corkum P, Tannock R, Moldofsky H, 1998, Sleep Disturbances in Children With Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 37(6): 637–646.

Gruber R, 2009, Sleep Characteristics of Children and Adolescents With Attention Deficit-Hyperactivity Disorder. Child & Adolescent Psychiatric Clinics of North America, 18(4): 863–876.

Guran T, Arman A, Akcay T, et al., 2011, Cognitive and Psychosocial Development in Children With Familial Hypomagnesaemia. Magnesium Research, 24(1): 7–12.

Ben-Artsy A, Glicksohn J, Soroker N, et al., 1996, An Assessment of Hemineglect in Children With Attention Deficit Hyperactivity Disorder. Developmental Neuropsychology, 12(3): 271–281.

Volpe S, 2013, Magnesium in Disease Prevention and Overall Health. Advances in Nutrition, 4(3): 378S.

Ziegler T, Leader L, Nelson S, et al., 2000, Glutamine and the Gastrointestinal Tract. JPEN Journal of Parenteral and Enteral Nutrition, 24(6 Suppl): S61–S66.

Dashwood R, Visioli F, 2025, L-Theanine: From Tea Leaf to Trending Supplement – Does the Science Match the Hype for Brain Health and Relaxation?. Nutrition Research, 134: 39–48.

Ates M, Kizildag S, Yuksel O, et al., 2019, Dose-Dependent Absorption Profile of Different Magnesium Compounds. Biological Trace Element Research, 192(2): 144–251.

Belardo A, Gevi F, Zolla L, 2019, The Concomitant Lower Concentrations of Vitamins B6, B9 and B12 May Cause Methylation Deficiency in Autistic Children. The Journal of Nutritional Biochemistry, 70: 38–46.

Previous article in this issue

Next article in this issue